Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daicel's Total Liabilities for the quarter that ended in Mar. 2026 was 円463,552 Mil.
Daicel's quarterly Total Liabilities
increased
from Sep. 2025 (円454,699.00 Mil) to Dec. 2025 (円483,882.00 Mil) but then
declined
from Dec. 2025 (円483,882.00 Mil) to Mar. 2026 (円463,552.00 Mil).
Daicel's annual Total Liabilities
declined
from Mar. 2024 (円463,762.00 Mil) to Mar. 2025 (円438,796.00 Mil) but then
increased
from Mar. 2025 (円438,796.00 Mil) to Mar. 2026 (円463,552.00 Mil).
The historical data trend for Daicel's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Daicel's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of 円463,552 Mil mean?
Daicel (TSE:4202) has a Total Liabilities of 円463,552 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Daicel and its competitors.
Is Daicel's Total Liabilities too high?
Daicel's current Total Liabilities is 円463,552 Mil. Overall, Daicel has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daicel's Total Liabilities compare to LIN and SHW?
Daicel's Total Liabilities of 円463,552 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Daicel and its competitors. Daicel's current Total Liabilities is 円463,552 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daicel stock overvalued right now?
Based on GuruFocus' analysis, Daicel (TSE:4202) is currently considered Fairly Valued. The stock's GF Value™ is 円1,472.26, compared to a current price of 円1,466.00 — trading 0.4% below its estimated fair value. The current Total Liabilities is 円463,552 Mil. Daicel's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Daicel (TSE:4202), the current Total Liabilities is 円463,552 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daicel (TSE:4202) Overvalued in 2026?
Based on GuruFocus' analysis, Daicel stock appears to be undervalued.
The current stock price of 円1,466.00 is trading 0.4% below its estimated GF Value™ of 円1,472.26.
GuruFocus considers Daicel to be Fairly Valued.
Key valuation signals for TSE:4202:
Total Liabilities: 円463,552 Mil
GF Value™: 円1,472.26 vs. price of 円1,466.00 (0.4% below fair value)
No single metric tells the full story. See the TSE:4202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daicel Corp is a Japanese chemical company engaged in engineering plastics, materials, medical health care, safety, smart materials, & other businesses. The company operates through five segments. The Engineering Plastics segment includes polyacetal resins, PET resins, liquid crystal polymers, and related products. The Material segment covers acetic acid, derivatives, acetate tow, cellulose acetate, and cosmetic raw materials. The Medical Health Care segment provides enantiomer separation columns and health food materials. The Safety segment offers inflators for automobile airbags and circuit breakers, while the Smart segment handles caprolactone derivatives, epoxy compounds, semiconductor materials, and functional films. The Others segment includes membranes and transportation warehouses.
83GF Score
Get the complete analysis for TSE:4202
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4202 has been successfully added to your 
